Optimizing the safety of antibody–drug conjugates for patients with solid tumours

P Tarantino, B Ricciuti, SM Pradhan… - Nature reviews Clinical …, 2023 - nature.com
Over the past 5 years, improvements in the design of antibody–drug conjugates (ADCs)
have enabled major advances that have reshaped the treatment of several advanced-stage …
被引用次数：49 相关文章

Optimizing the safety of antibody-drug conjugates for patients with solid tumours

P Tarantino, B Ricciuti, SM Pradhan… - Nature reviews … - pubmed.ncbi.nlm.nih.gov
Over the past 5 years, improvements in the design of antibody-drug conjugates (ADCs) have
enabled major advances that have reshaped the treatment of several advanced-stage solid …

Optimizing the safety of antibody-drug conjugates for patients with solid tumours.

P Tarantino, B Ricciuti, SM Pradhan… - Nature reviews. Clinical …, 2023 - europepmc.org
Over the past 5 years, improvements in the design of antibody-drug conjugates (ADCs) have
enabled major advances that have reshaped the treatment of several advanced-stage solid …